Heart+ILD Research (12)
12 papers in the Heart+ILD topic, indexed by PF-Atlas from PubMed and global journals.
Cross-disease research. These studies are from related fibrotic, oncologic or regenerative fields and are tracked for mechanistic relevance to IPF. They are not direct evidence for treating idiopathic pulmonary fibrosis.
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation · Journal of the American College of Cardiology · 2023
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension · European Heart Journal · 2022
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension · European Respiratory Journal · 2022
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update · Journal of Clinical Oncology · 2021
- Acute kidney injury · Nature Reviews Disease Primers · 2021
- Society for Immunotherapy of Cancer clinical practice guideline on immune checkpoint inhibitor-related adverse events · Journal for ImmunoTherapy of Cancer · 2021
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia · Chinese Medical Journal · 2020
- COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives · Nature Reviews Cardiology · 2020
- Psychometric properties of the EQ-5D-5L: a systematic review of the literature · Quality of Life Research · 2020
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment · Clinical Rheumatology · 2020
- Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management · Heart Rhythm · 2020
- Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma · Liver Cancer · 2020
Medical disclaimer. Research listings are for information only and are not medical advice.